July 9, 2020 – Two more pharmaceutical companies have issued a recall for a medication used to control high blood sugar in people with Type 2 diabetes because it may contain a carcinogen.
Lupin Pharmaceuticals Inc. issued the recall for all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 1000 mg because “additional analysis revealed that certain tested batches were above the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (NDMA),” according to a statement posted by the U.S. Food and Drug Administration.
SOBERSTARS! – Jan. 2, 2025 - After successfully completing Dry January, when one gives up alcohol…
DEAD BUT NOT FORGOTTEN – DEC 14, 2024 - Parade annually celebrates the lives of…
VIDEO – SHARING THE MESSAGE – Dec. 24, 2024 - “My husband’s great uncle drank…
SHE’S BAAAACK – Dec. 24, 2024 - Britney is moving into 2025 determined to stay…
VIDEO – SAMPLING NOTHING WORKS – Dec. 25, 2024 - Andrea McCarthy told friends and…
“People can become psychotic.” – Dec. 22, 2024 - Heidi Lawrence’s daughter was 14 when…